van Beek R, Schröder C H, de Jong M C, Monnens L A
Department of Pediatrics, St. Radboud Hospital, University of Nijmegen, The Netherlands.
Helv Paediatr Acta. 1988 Aug;43(1-2):33-40.
Prolonged CAPD is reported to cause a gradual loss of ultrafiltration capacity. The composition of the dialysis fluid and the occurrence of recurrent peritonitis episodes are assumed to be responsible for this diminished ultrafiltration. A group of 22 infants and young children (mean age 3.8 years) is described. CAPD was performed in these children for a mean period of 17.8 months. There was no loss of ultrafiltration capacity, determined by the repeated volume method, in the first 18 months of treatment. Urea clearance remained stable. These data could be calculated in half of the patients, the other patients behaved clinically in the same way. In one patient ultrafiltration capacity decreased after 4 years of treatment. It is concluded that, in young children, CAPD is a reliable renal replacement therapy, although peritonitis remains a matter of concern.
据报道,长期持续性非卧床腹膜透析(CAPD)会导致超滤能力逐渐丧失。透析液的成分和反复发生的腹膜炎发作被认为是超滤能力下降的原因。本文描述了一组22名婴幼儿(平均年龄3.8岁)。这些儿童进行CAPD的平均时间为17.8个月。在治疗的前18个月,通过重复容量法测定,超滤能力没有丧失。尿素清除率保持稳定。这些数据可以在一半的患者中计算得出,其他患者的临床情况相同。一名患者在治疗4年后超滤能力下降。结论是,在幼儿中,CAPD是一种可靠的肾脏替代疗法,尽管腹膜炎仍然是一个令人担忧的问题。